ATLANTA — Stereotactic radiosurgery (SRS) alone should be the favored first-line radiation therapy option for cancer patients younger than 50 years of age who have a minimal number of brain metastases ...
Despite being widely used after surgery for brain metastases in cancer patients, stereotactic radiosurgery (SRS) has not been proven to be effective in medicine's most important testing ground: a ...
Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results